Pesticide Sensitivity and Genetics: PON1, CYP, and GST

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on genetics & detoxification. Browse all Genetics & Detoxification education

Two people can face the same pesticide exposure and react very differently. Part of that difference is dose and duration, but part of it is written in your DNA. The enzymes that break down organophosphates and other common agricultural chemicals vary from person to person, and that variation helps explain why some individuals clear these compounds efficiently while others are more sensitive.

How the body processes pesticides

Detoxification generally runs in two phases. Phase I enzymes, mostly cytochrome P450 proteins, chemically modify a foreign compound. Phase II enzymes then attach a molecule that makes it water-soluble and easy to excrete. Organophosphate pesticides add a twist: they are potent inhibitors of acetylcholinesterase, the enzyme that clears the neurotransmitter acetylcholine. How quickly your body neutralizes these chemicals before they reach that target is where genetics plays a decisive role.

PON1: the paraoxonase gene

The single most studied gene in pesticide toxicology is PON1, which encodes paraoxonase-1 — an enzyme that hydrolyzes the toxic metabolites of many organophosphates. Two common variants matter most. The Q192R variant (rs662) changes how efficiently PON1 breaks down specific compounds, so the "faster" and "slower" forms handle different pesticides at different rates. A promoter-region variant (rs854560, the L55M change) influences how much enzyme you produce. Together they mean your baseline capacity to detoxify organophosphates is partly inherited.

Other detox genes: CYP450, GST, BCHE, and NAT2

PON1 does not act alone. CYP2D6 and other cytochrome P450 genes govern Phase I activation and can convert some pesticides into more or less reactive forms. The glutathione S-transferase genes GSTM1 and GSTT1 — commonly deleted entirely in a large share of people — handle Phase II clearance, and their absence is linked to higher oxidative stress after chemical exposure. BCHE (butyrylcholinesterase) provides a secondary buffer against organophosphates, and NAT2 acetylator status shapes how quickly certain compounds are neutralized.

What the research shows

Occupational and agricultural health studies have repeatedly linked PON1 genotype and activity to differences in organophosphate sensitivity, and research in farmworkers has connected GSTM1 and GSTT1 status to markers of oxidative stress after exposure. The consistent message is that genetic variation modifies risk — it raises or lowers your resilience — but it never overrides the basic principle that reducing exposure protects everyone regardless of genotype.

What your PlexusDx results reveal

For a detoxification topic, the relevant genes are the paraoxonase, cytochrome P450, and glutathione-transferase families rather than unrelated markers. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across your DNA, giving you pathway-level context about how your body is wired. It is a map, not a verdict: your genotype does not change, but knowing it can sharpen the questions you bring to a qualified healthcare provider. The test reports on your biology — it does not tell you what to put in your body, diagnose a condition, or predict how you will respond to any specific medication.

Reducing exposure and next steps

Genetics sets your baseline resilience; behavior sets your dose. Evidence-based, general protective steps apply to everyone: washing produce, choosing appropriate protective equipment for occupational exposure, ventilating treated areas, and following label safety guidance. If you work around agricultural chemicals or have symptoms you suspect are exposure-related, a qualified healthcare provider — or occupational medicine specialist — is the right person to evaluate you. Genetic insight can inform that conversation; it does not diagnose poisoning or replace medical assessment.

Frequently Asked Questions

Can genetics make me more sensitive to pesticides?

Yes. Variants in PON1, the CYP450 family, and the glutathione S-transferase genes GSTM1 and GSTT1 influence how efficiently your body clears organophosphates and other chemicals. That shifts your resilience up or down. Genetics modifies risk, but reducing exposure protects everyone, and any suspected poisoning needs a qualified provider.

What is PON1 and why does it matter for pesticides?

PON1 encodes paraoxonase-1, an enzyme that breaks down the toxic metabolites of many organophosphate pesticides. Common variants rs662 and rs854560 change how much enzyme you make and how efficiently it works, so your inherited PON1 profile partly determines your baseline capacity to detoxify these compounds.

Does the Precision Peptide Genetic Test detect pesticide poisoning?

No. It provides pathway-level context, not a diagnosis. The test analyzes detoxification-related genes to describe how your biology is wired. It cannot detect an exposure, confirm poisoning, or predict treatment — those require clinical evaluation by a qualified healthcare provider.

How can I lower my risk from pesticide exposure?

Reduce the dose that reaches you. Wash produce thoroughly, use proper protective equipment for occupational tasks, ventilate treated spaces, and follow product safety labeling. These general steps protect everyone regardless of genotype. If you have exposure-related symptoms, seek evaluation from a qualified provider promptly.

Want pathway-level context on your own detoxification pathways? The Precision Peptide Genetic Test translates your DNA into insights you can review with a qualified provider — education about your biology, not a diagnosis.

Disclaimer: The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, or prevent any disease. Consult a qualified healthcare provider before beginning any peptide protocol.

This article is part of the PlexusDx Education Hub. Browse all Genetics & Detoxification education